Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients (CTOTC-11)

National Institute of Allergy and Infectious Diseases (NIAID) logo

National Institute of Allergy and Infectious Diseases (NIAID)

Status

Completed

Conditions

Solid Organ Transplant Recipients
Parent(s)/Guardian of Referenced Transplant Recipients

Treatments

Other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02892266
DAIT CTOTC-11

Details and patient eligibility

About

This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine. Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.

Enrollment

124 patients

Sex

All

Ages

12 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The patient:

  • and/or their parent(s)/guardian must be able to understand and provide informed consent in English or Spanish;
  • is prescribed tacrolimus (either brand or generic formulation); and
  • has been seen in the enrolling center's clinic at least twice in the last two years.

Exclusion criteria

The patient:

  • received a transplant less than 18 months prior to enrollment;
  • has had more than one transplant (including marrow replacement);
  • or their parent(s)/guardian is actively psychotic or severely disoriented due to any cause, including hepatic encephalopathy (temporary exclusion);
  • or their parent(s)/guardian has been diagnosed with severe intellectual disability as defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5);
  • is not medically stable or is hospitalized;
  • is currently enrolled in a study that aims to improve adherence to medical recommendations;
  • is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of Post-Traumatic Stress Disorder (PTSD) at enrollment;
  • is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.

Trial design

124 participants in 1 patient group

Adolescent Transplant Recipients
Description:
Questionnaire battery at enrollment (Participants and their parents/guardians) Clinical data from patient's chart (6 months of retrospective data & 6 months of prospective tacrolimus trough level data)
Treatment:
Other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems